Skip to main content About News Giving All Departments Contact Us Site Map
 University of Texas Southwestern Medical School
 
Search       
Print Friendly  
spacer Home Education Research Patient Care Faculty & Administration Resource Careers
For Patients & Public For Health Care Professionals Clinics and Hospitals
| Home > Patient Care > For Patients & Public > Care Centers and Specialties > Nutrition and Metabolic Diseases >
Division of Nutrition & Metabolic Diseases - About Us
 Home  
 About Us 
 Laboratories 
 Faculty & Staff 
 Fellows 
 Open Positions 
 Latest Developments 
  
  
 

 

The Division of Nutrition and Metabolic Diseases is actively involved in clinical and basic research pertaining to the disorders of human nutrition and metabolism (such as obesity, other body fat disorders, diabetes and hyperlipidemias). The faculty in the Division are also involved in training and teaching of students and postdoctoral fellows. The faculty provides consultation to the patients with lipid disorders, diabetes and adipose tissue disorders.

Research

The research studies pertain to inherited and acquired lipodystrophies, obesity, body composition, insulin resistance, management of diabetes mellitus and hyperlipidemia.

Presently, we are investigating phenotypic characteristics, metabolic abnormalities, and underlying basis of various types of lipodystrophies and other disorders of adipose tissues (such as Multiple Symmetric Lipomatosis etc.). Mutations of the AGPAT2 and BSCL2 genes in patients with congenital generalized lipodystrophy have been reported recently by us. In addition, we have reported mutations in the Lamin A/C gene in familial partial lipodystrophy (Dunnigan variety) and in the PPAR-ÿ in a patient with familial partial lipodystrophy. We have also reported remarkable success in the treatment of lipodystrophies using recombinant leptin therapy.

Moreover, our group has been studying pathophysiology and management of lipodystrophy in HIV-infected patients. We are investigating the effect of fish oil supplements, sitostanol, and dietary intervention to treat hyperlipidemia in HIV patients on protease inhibitor combination therapy.

Our recent studies highlight the importance of dietary fiber in the management of diabetes mellitus. We have also contributed significantly to the understanding of the drug treatment of diabetic dyslipidemia. Several studies have evaluated the efficacy and safety of nicotinic acid, lovastatin, gemfibrozil, and cholestyramine in treating lipid disorders in patients with diabetes.

We are also studying the effects of plant stanols (derivatives of sitosterol) in hypercholesterolemic patients. The role of dietary adjuncts, such as functional foods and nutraceuticals, in the management of moderate hypercholesterolemia and in their potential utility in augmenting the cholesterol-lowering effect of diet in patients already on statin therapy are being actively pursued.

Training

Presently, we provide clinical and research training to the following personnel:

  • Medical students and dietetic students
  • Doris Duke clinical research fellows
  • Postdoctoral research fellows
  • Endocrinology, metabolism and diabetes fellows
  • Nutrition and metabolic diseases fellows

Patient care

We are managing patients with obesity, lipoprotein disorders, diabetes mellitus, and body fat disorders such as lipodystrophies. Our faculty and clinical fellows provide consultation and services at the Department of Veterans Affairs Medical Center’s Diabetes and Lipid clinics. The patients with adipose tissue disorders are evaluated at the Clinical and Translational Research Center